Forum 2000 - Prostate Cancer Research Foundation

working and living with prostate cancer blogger

Home

The Forum

Previous Forums

Forum 2000

This fourth meeting took place at the Hyatt Regency, Bethesda, USA from 10 - 12 March 2000, and was co-hosted by the US Department of Defense Centre for Prostate Disease Research.

Delegates from the fourth Forum held in 2000

Session Titles:

Molecular Genetics and the Pathogenesis of Prostate Cancer

Early Detection and Screening for Prostate Cancer

Factors and Markers of Diagnosis Progression and Prognostication

Hormones and Novel Therapy for Localised, Locally Advances and Advances CaP

NRPC and Novel Therapeutics

Delegates:

Dr Jan Adolfsson Stockholm, Sweden	Dr Chris Bangma Rotterdam, Netherlands	Dr Arie Belldegrun Los Angeles, USA	Dr George Blackledge AstraZeneca

Sir Walter Bodmer Oxford, England	Dr Michael Brawer Seattle, USA	Mr Noel Clarke Manchester, England	Prof Gus Dalgleish London, England

Dr Anthony D'Amico Boston, USA	Dr Ros Eeles Surrey, England	Dr Shin Egawa Kanagawa, Japan	Prof Peter Ekman Stockholm, Sweden

Dr Judah Folkman Boston, USA	Dr Norman Greenberg Texas, USA	Prof Freddie Hamdy Sheffield, England	Mr Roger Kirby London, England

Prof Hans Lilja Malmo, Sweden	Dr Mark Litwin Los Angeles, USA	Dr David McLeod Washington, USA	Mrs Jean Mossman London, England

Dr Judd Moul Rockville, USA	Mr Gordon Muir London, England	Dr Peter Mulders Nijmegen, Netherlands	Dr Susan Neuhausen Utah, USA

Prof Don Newling Amsterdam, Netherlands	Prof Tim Oliver London, England	Dr Robert Reiter Los Angeles, USA	Dr Johng Rhim Rockville, USA

Prof Jack Schalken Nijmegen, Netherlands	Prof Fritz Schroder Rotterdam, Netherlands	Sr Isabell Sesterhenn Washington, USA	Dr Jonathan Simons Baltimore, USA

Dr Shiv Srivastava Rockville, USA	Dr John Trachtenberg Toronto, Canada	Dr Robert Vessella Seattle, USA	Dr Tapio Visakorpi Tampere, Finland

Dr Bill Watson Dublin, Ireland	Dr Peter Wrigley Harrogate, England

< Prev		Next >